Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled

Rong He1,2, Fei Lin2,3, Zehui Deng4

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.

SAGE Open Medicine
|January 22, 2024
PubMed
Abstract